Detalhe da pesquisa
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439329
2.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Hematol Oncol
; 42(4): e3290, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38818978
3.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Ann Hematol
; 103(1): 125-132, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731147
4.
The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.
Support Care Cancer
; 31(6): 350, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227523
5.
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Int J Mol Sci
; 23(21)2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362130
6.
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma.
Support Care Cancer
; 29(11): 6973-6980, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990881
7.
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Am J Hematol
; 95(9): 1030-1037, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32419224
8.
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.
Oncologist
; 23(4): 454-460, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29317554
9.
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience.
Anticancer Drugs
; 29(4): 371-372, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420336
10.
Safety and comfort of domestic bortezomib injection in real-life experience.
Support Care Cancer
; 26(9): 3111-3116, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574618
11.
Secondary syphilis mimicking malignancy: A case report and review of literature.
J Infect Chemother
; 23(8): 576-578, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28456488
12.
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.
Support Care Cancer
; 27(5): 1587-1588, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30671660
13.
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis.
Ann Hematol
; 96(4): 697-699, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197723
14.
Pegfilgrastim in Supportive Care of Hodgkin Lymphoma.
Cancers (Basel)
; 14(17)2022 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077600
15.
Coexistence of TEMPI syndrome and leukocytoclastic vasculitis successfully treated with autologous stem cell transplantation.
EJHaem
; 3(4): 1385-1387, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467823
16.
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone.
Support Care Cancer
; 24(12): 4835-4837, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27726031
17.
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
Cancers (Basel)
; 13(18)2021 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572794
18.
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments.
Front Oncol
; 10: 624661, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33680948
19.
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report.
Medicine (Baltimore)
; 99(33): e21440, 2020 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871991
20.
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial.
J Clin Med
; 9(2)2020 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32024148